Base by Base podcast

478: Pathogenic, benign or uncertain: the UK rules for reading a variant

18/11/2026
0:00
18:24
Retroceder 15 segundos
Avanzar 15 segundos

Durkie M et al., Journal of Medical Genetics - When a genetic test finds a rare variant, someone has to decide whether it causes the disease, is harmless, or remains uncertain. These best practice guidelines from the Association for Clinical Genomic Science set out how UK NHS genomic laboratories should make that call, aligning with the ACMG/AMP and ClinGen frameworks. They cover small sequence variants and copy number variants, extend guidance to mitochondrial, non-coding, reduced penetrance and hypomorphic variants, and spell out what should and should not appear in a laboratory report. Key terms: variant classification, ACMG/AMP guidelines, variant of uncertain significance, copy number variants, rare disease.

Study Highlights:
An expert multidisciplinary group developed the guidelines, which were reviewed and ratified by ACGS members, and they provide 25 general recommendations, detailed specifications for each ACMG evidence code and recommended report wording. Evidence is combined with a Bayesian points framework, and except for stand-alone benign codes at least two criteria are needed to call a variant (likely) pathogenic or (likely) benign. Variants of uncertain significance, whose likelihood of being pathogenic ranges from 10% to 90%, are sub-classified into three groups for internal use, and those with limited evidence where further testing would not upgrade them are not reported. A mini impact assessment showed that changing evidence weights alone would downgrade 64 of 210 likely pathogenic variants (30.5%) to VUS. The guidelines also stress phenotype specificity, a multidisciplinary approach and sharing classifications in ClinVar, CanVar-UK and DECIPHER.

Conclusion:
The ACGS guidelines offer a unified framework for consistent variant classification and reporting across UK NHS rare disease testing, with particular attention to variants of uncertain significance. They are expert consensus recommendations rather than a study with new patient data, they are written mainly for NHS laboratories, and the authors note that classifications reflect the evidence at the time and may change as data and guidance evolve.

Article title:
Association for Clinical Genomic Science (ACGS) Best Practice Guidelines for Variant Classification in Rare Disease

First author:
Durkie M

Journal:
Journal of Medical Genetics

DOI:
10.1136/jmg-2026-111835

Reference:
Durkie M., Cassidy E., Owens M., Berry I., Taylor J., Haigh S., et al. Association for Clinical Genomic Science (ACGS) Best Practice Guidelines for Variant Classification in Rare Disease. Journal of Medical Genetics, jmg-2026-111835. (2026). https://doi.org/10.1136/jmg-2026-111835

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase
More at basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/acgs-variant-classification-guidelines-rare-disease

QC:
This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded.

QC Summary:
- sentences checked: 159
- supported by the article: 159
- flagged and reviewed by a human: 0
- metadata checks passed: 3 of 4...

Otros episodios de "Base by Base"